From drugstore pregnancy tests to glucose monitors, at-home medical devices and diagnostics have been part of the healthcare landscape for decades.
The COVID-19 pandemic was a watershed moment for the industry, funneling a new level of investment and energy into this previously slow-growing space.
Driven by the need for reliable, cost-efficient COVID-19 tests as well as the expansion of telehealth services, companies achieved faster, more focused innovation in at-home medical device development than ever before.
Since then, developers, manufacturers, and suppliers have worked to continue this momentum across a wide spectrum of 
